Rutgers Is A Test Site For First-Ever Kids' Vaccine For Lyme Disease
April 18, 20233 min read500 words
Published: April 18, 2023  |  3 min read500 words
This April, Rutgers launched a pediatric study for a vaccine for Lyme disease. This would be the first-ever vaccine to prevent Lyme disease in children ages 5 to 17. There is no existing Lyme disease vaccine for adults. Rutgers has been selected as a clinical trial site by Pfizer...
Rutgers Is A Test Site For First-Ever Kids' Vaccine For Lyme Disease Read more

No article scores yet.

There are no critic or public scores for this article yet.
Investigative1
critic reviews: 0
public reviews: 1
No reviews
img-contested
N/A
critic score
1 reviews
img-trusted
89%
public score
9 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
1 reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

Investigative
April 18, 2023
Simple to understand yet very investigative article. They provided a clear analysis of what the study is and how they'll conduct it. Well written, and a great article overall.
April 18, 2023
Is this helpful?